-
Changes in lower urinary tract function after minimally invasive nerve-sparing for complete excision of endometriosis: An observational study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-18 Fernanda Hack Gomes, Marlon de Freitas Fonseca, Luciano Alves Favorito, Mauro Poggiali Gasparoni, Fernando Salles da Silva Filho, André Luiz Lima Diniz, José Anacleto D. de Resende Júnior
The objective of this paper is to evaluate changes in lower urinary tract symptoms (LUTS), severity of pain and urodynamic parameters after minimally invasive nerve-sparing surgery for patients with endometriosis.
-
Can we predict and manage persistent storage and voiding LUTS following bladder outflow resistance reduction surgery in men? ICI‐RS 2023 Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-13 Tufan Tarcan, Hashim Hashim, Sachin Malde, Sanjay Sinha, Arun Sahai, Omer Acar, Caroline Selai, Enrico Finazzi Agro, Paul Abrams, Alan Wein
AimsLower urinary tract symptoms (LUTS) persist in up to 50% of patients after bladder outflow resistance reduction surgery (BORRS) in men. Our think tank aims to address the predictive factors for persistent LUTS after BORRS and to propose the recommendations for future research to enable improved better patient counseling and selection by more accurate prediction of treatment outcome.MethodsA think
-
An individual participant meta‐analysis of mirabegron in multiple sclerosis and spinal cord injury Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-13 Blayne Welk, Jan Krhut, Radek Sýkora
IntroductionOur objective was to conduct an individual patient data meta‐analysis (IPDMA) of the two published randomized placebo‐controlled trials of mirabegron in people with neurogenic lower urinary tract dysfunction (NLUTD) due to spinal cord injury (SCI) or multiple sclerosis (MS).MethodsWe identified two randomized, placebo‐controlled trials. We extracted individual patient data from the trials
-
Melatonin and melatonin receptor agonists in the treatment of nocturia: A systematic review Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-08 Christine Anh Burke, Victor W. Nitti, Lynn Stothers
AimCauses of nocturia may extend beyond primary bladder pathology and it has been commonly associated as a side effect of sleep disorders. This has led to the study of melatonin and melatonin receptor agonists as a primary treatment for nocturia hypothesized to be secondary to sleep disorders. We aim to systematically review the efficacy and reported safety of melatonin and melatonin receptor agonists
-
Black women's perspectives on bladder health: Social-ecological and life course contexts Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-07 Beverly R. Williams, Sonya S. Brady, Elise C. Levin, Oluwateniola Brown, Terri H. Lipman, Heather Klusaritz, Jesse Nodora, Tamera Coyne-Beasley, Sara Putman, Sheila Gahagan, Kathryn L. Burgio
This paper explores Black women's perspectives on bladder health using a social-ecological conceptual framework and life course perspective.
-
Reply to “Lower urinary tract (LUT) symptoms like over‐ (OAB) or underactive bladder (UAB) often are caused by pelvic organ prolapse (POP) in women and can often be cured by ligamentous POP‐repair” Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-07 Enrico Finazzi Agrò, Maurizio Serati, Vito Mancini
-
Conformity of ChatGPT recommendations with the AUA/SUFU guideline on postprostatectomy urinary incontinence Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-07 Vicktor B. P. Pinto, Matheus F. de Azevedo, Marcelo L. Wroclawski, Guilherme Gentile, Vinicius L. M. Jesus, Jose de Bessa Junior, William C. Nahas, Carlos A. R. Sacomani, Jaspreet S. Sandhu, Cristiano M. Gomes
IntroductionArtificial intelligence (AI) shows immense potential in medicine and Chat generative pretrained transformer (ChatGPT) has been used for different purposes in the field. However, it may not match the complexity and nuance of certain medical scenarios. This study evaluates the accuracy of ChatGPT 3.5 and 4 in providing recommendations regarding the management of postprostatectomy urinary
-
Sex‐specific independent risk factors of urinary incontinence in acute stroke patients: A multicentre registry‐based cohort study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-07 Adam Fluck, Christopher H. Fry, Brendan Affley, Puneet Kakar, Pankaj Sharma, David Fluck, Thang S. Han
BackgroundThe presence of urinary incontinence (UI) in acute stroke patients indicates poor outcomes in men and women. However, there is a paucity and inconsistency of data on UI risk factors in this group and hence we conducted a sex‐specific analysis to identify risk factors.MethodsData were collected prospectively (2014–2016) from the Sentinel Stroke National Audit Program for patients admitted
-
How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-07 Camille Mailho, Benoit Peyronnet, Marianne De Seze, Alexia Even, Maire‐Aimée Perrouin‐Verbe, Gérard Amarenco, Emmanuel Chartier‐Kastler, Loic Le Normand, Andrea Manunta, Gilles Karsenty, Jacques Kerdraon, Alain Ruffion, Christian Saussine, Frédérique Le Breton, Benjamin Bernuz, Evelyne Castel‐Lacanal, Pierre Denys, Véronique Phé, Xavier Gamé
IntroductionNeurogenic detrusor overactivity (NDO) has a major impact on patients' quality of life and can lead to upper urinary tract complications. Intradetrusor botulinum toxin type A injections are administered as second‐line treatment to these patients following the failure of anticholinergic agents. The aim of the DETOX 2 study is to propose a consensus definition of the failure of intradetrusor
-
Comparison of perioperative adverse events following suburethral sling placement using synthetic mesh, autologous rectus fascia, and autologous fascia lata in a national surgical registry Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-01 Christopher X. Hong, Young Son, Vaishnavi J. Patel, Kimberly Lince, Priyanka Gupta
AimsTo assess and compare 30‐day perioperative adverse events following suburethral sling surgery using synthetic mesh, autologous rectus fascia, and autologous fascia lata in women.MethodsThis was a retrospective cohort study of patients who underwent fascial or synthetic sling placement for stress urinary incontinence between 2008 and 2021 using the American College of Surgeons' National Surgical
-
Effect of transcranial direct current stimulation combined with pelvic muscle training in women: Randomized, controlled, double‐blind, and clinical trial Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-01 Fernanda Ishida Corrêa, Ângela Cristina Ledur, Laura Uehara, Michele Lacerda de Andrade, João Carlos Ferrari Corrêa, Felipe Fregni
BackgroundPelvic floor muscle training (PFMT) is widely used for pelvic floor muscle (PFM) weakness in women; however, it has no prolonged effects.ObjectiveTo evaluate the effect of Transcranial Direct Current Stimulation (tDCS) associated with PFMT on PFM contraction, sexual function and quality of life (QoL) in healthy women.Study Design32 nulliparous women, aged 22.7 ± 0.42 years, were randomized
-
Statin administration ameliorates ischemia‐induced overactive bladder with improvement of blood flow and anti‐inflammatory effects in rats Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-03-01 Yuichi Ishizuka, Yohei Satake, Shingo Kimura, Shinichi Yamashita, Naoki Kawamorita, Akihiro Ito
AimsStatins are widely used to treat dyslipidemia and have been shown to reduce the risk of ischemic heart disease and cerebrovascular disease. The effects of statins on ischemia‐induced overactive bladder (OAB) and the associated mechanisms were investigated in a rat model of chronic pelvic ischemia.MethodsA pelvic ischemia model was created by iliac arterial injury (AI) and a high‐fat diet using
-
Characterizing the spectrum of bladder health and lower urinary tract symptoms among men: Results from the CARDIA study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-26 Alayne D. Markland, Gerhard Hellemann, Liang Shan, Sonya S. Brady, Jared D. Huling, Pamela J. Schreiner, Stephen Sidney, Stephen K. Van Den Eeden, Cora E. Lewis
ObjectivesTo operationalize a new definition for bladder health, we examined the distribution and impact of lower urinary tract symptoms (LUTS), along with risk factors, among men in the Coronary Artery Risk Development in Young Adults (CARDIA) study.MethodsLUTS were defined by American Urologic Association Symptom Index (AUASI) scores and impact on quality of life (QoL). Separate questions assessed
-
Perceived usefulness of the nurse–patient therapeutic relationship in the rehabilitation journey of people with urinary incontinence: A mixed‐method study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-26 Stefano Terzoni, Cristina Mora, Susanne Vahr Lauridssen, Serge N'Guessan, Chiara Sighinolfi Maria, Giorgia Gaia, Bernardo Rocco, Margarita Afonina, Serena Maruccia, Barbara Pinna, Mauro Parozzi, Paolo Ferrara, Anne Destrebecq, Jerome Marley
IntroductionDespite various studies on the impact of incontinence on patients' lives, the existing literature has not investigated the contribution of nursing care during rehabilitation in terms of quality of life. Fewer data, therefore, exist on the characteristics and perceived impact of the therapeutic relationship as part of the rehabilitation program.AimsTo investigate the characteristics of the
-
Primary bladder neck obstruction in men: The importance of urodynamic assessment and cystourethrography in measuring its severity Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-23 Joey El Khoury, Nicolas Hermieu, Camille Chesnel, Evanguelos Xylinas, Maëlys Teng, Idir Ouzaid, Jean François Hermieu, Gérard Amarenco, Claire Hentzen
ObjectivePrimary bladder neck obstruction (PBNO) is a condition primarily affecting young men, characterized by obstruction at the bladder neck, leading to lower urinary tract symptoms. The aim of this study was to identify a correlation between the severity of bladder neck opening impairment and urinary symptoms by means of urodynamic studies.Materials and MethodsA retrospective analysis was conducted
-
Shifts in patient preference of third‐line overactive bladder therapy after introduction of the implantable tibial nerve stimulator Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-23 Anjali Kapur, Arshia Aalami Harandi, Jacob Hartman‐Kenzler, Jason Kim
IntroductionThird‐line therapies for overactive bladder (OAB) that are currently recommended include intravesical Onabotulinumtoxin‐A injections (BTX‐A), percutaneous tibial nerve stimulation (PTNS), and sacral neuromodulation (SNM). The implantable tibial nerve stimulator (ITNS) is a novel therapy that is now available to patients with OAB.ObjectiveThe objective of this study was to analyze shifts
-
Evaluating the quality of life impact of recurrent urinary tract infection: Validation and refinement of the Recurrent UTI Impact Questionnaire (RUTIIQ) Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-22 Abigail F. Newlands, Melissa Kramer, Lindsey Roberts, Kayleigh Maxwell, Jessica L. Price, Katherine A. Finlay
Background and AimsRecurrent urinary tract infection (rUTI) has significant negative consequences for a wide variety of quality of life (QoL) domains. Without adequate validation and assessment of the unique insights of people living with rUTI, clinical results cannot be fully understood. The Recurrent UTI Impact Questionnaire (RUTIIQ), a novel patient‐reported outcome measure of rUTI psychosocial
-
Association between TV and/or video time and nocturia in adults: An analysis of the National Health and Nutrition Examination Survey Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-21 Junwei Wang, Aiwei Zhang, Miaoyong Ye, Cunming Zhang
AimsThis study aimed to examine the correlation between television (TV) and/or video viewing time and the occurrence of nocturia in adults.MethodsAn analysis of data from the National Health and Nutrition Examination Survey for 2011–2016 was conducted, involving 13 294 adults aged 20 and older. The main outcome was specified as nocturia, which refers to the requirement of urinating two or more times
-
-
Elucidating the causal landscape: Mendelian randomization analysis of lifestyle and physiological factors in stress urinary incontinence Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-20 Qinggang Liu, Linna Wang, Limin Liao, Huiling Cong, Yi Gao
PurposeTo explore the potential causal links between obesity, type 2 diabetes (T2D), and lifestyle choices (such as smoking, alcohol and coffee consumption, and vigorous physical activity) on stress urinary incontinence (SUI), this study employs a Mendelian Randomization approach. This research aims to clarify these associations, which have been suggested but not conclusively established in prior observational
-
Comparative study of mobile acoustic uroflowmetry and conventional uroflowmetry: A systematic review and meta analysis Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-19 Ervandy Rangganata, Harrina Erlianti Rahardjo, Nur Rasyid, Fina Widia, I Made Murwantara, Pujianto Yugopuspito, Bayu Gemilang, Fakhri Zuhdian Nasher, Yasmina Zahra Syadza, Kevin Yonathan, Ponco Birowo
IntroductionUroflowmetry is a noninvasive measurement of the volume of urine excreted over time. Conventional uroflowmetry has become the main modality of urine flow measurement within time. However, this method requires the patient to be present in the hospital or healthcare setting, thus sometimes making the patients feel uncomfortable to undergo the examination. This led to multiple measurements
-
The effects of a galectin-3 inhibitor on bladder pain syndrome in mice with cyclophosphamide-induced cystitis Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-14 Helong Xiao, Ting Wang, Bo Gao, Junjiang Liu, Shoubin Li, Jianguo Ma
To explore the effect of blocking galectin-3 in the bladder pain syndrome associated with interstitial cystitis.
-
A surgical perspective on the history of vesicovaginal fistula repair in the United States Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-14 Giulia M. Ippolito, Shenelle N. Wilson, Joel Howell
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Novel use of contrast enhanced ultrasonography with urodynamics in children: A comparison study to fluoroscopy Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-14 Emmett Kennady, Dylan Hutchison, Sean T. Corbett, Susan Leroy, Kathryn Morgan, Reza Daugherty, Nicole Kapral, Nora G. Kern
Video urodynamics (UDS) has classically been performed using fluoroscopy (fluoro). Contrast enhanced voiding ultrasonography (ceVUS) has rarely been reported for use with UDS. This is the first study to compare the imaging characteristics of ceVUS versus fluoro UDS.
-
Brainstem nuclei responsive to cystometry in both endometriosis and cystitis rat models: C-fos immunohistochemistry study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-13 Ayah A. Bashkami, Ezidin G. Kaddumi, Mohamad Al-Saghbini, Afnan J. Kenana
Although the co-occurrence of interstitial cystitis (IC) and endometriosis (ENDO) is remarkably high, the exact pathophysiology for this co-occurrence is unknown. The convergence of the inputs from the involved structures to the same neuronal centers may suggest neuronal hyperexcitability as a mechanism for this co-occurrence.
-
Multi-omics analyses uncover metabolic signatures and gene expression profiles of interstitial cystitis/bladder pain syndrome Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-12 Xianyanling Yi, Jin Li, Zeyu Han, Tianyi Zhang, Dazhou Liao, Xiaoyan Lv, Jianzhong Ai
We explore molecular and metabolic pathways involved in interstitial cystitis (IC) with integrating multi-omics analysis for identifying potential diagnostic and therapeutic targets.
-
Patient and physician decision-making dynamics in overactive bladder care: A mixed methods study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-09 Hannah M. Sitto, Casey N. Brodsky, Daniela Wittmann, Lauren P. Wallner, Courtney Streur, Melissa DeJonckheere, John S. Stoffel, Anne P. Cameron, Aruna Sarma, James Quentin Clemens, Giulia M. Ippolito
Overactive bladder management includes multiple therapeutic options with comparable efficacy but a range of administration modalities and side effects, creating an ideal setting for shared decision-making. This study investigates patient and physician health beliefs surrounding decision-making and expectations for overactive bladder with the aim of better understanding and ultimately improving decision-making
-
Cover Image, Volume 43, Number 2, February 2024 Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-04 Gamal Ghoniem, Rongwei Mao, David Alexander Csuka, Bilal Farhan, Sami Souccar
-
The effect of the COVID-19 lockdown on women presenting with pelvic organ prolapse Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-06 Rachan Ghandour, Alexa Courtepatte, Melissa Plummer, Vatche A. Minassian
To determine whether there is a difference in pelvic organ prolapse (POP) stage at time of presentation after lifting coronavirus disease (COVID-19) lockdown restrictions, as compared to before the lockdown. Enhancing our understanding of how healthcare utilization for pelvic floor disorders may be affected by limited accessibility, such as the COVID-19 pandemic, could prove invaluable for similar
-
Treatment of the infected sacral nerve stimulator: A scoping review Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-06 Jessica Wynn, Ellen Kelsey, Kathryn McLeod
Sacral nerve stimulators (SNSs) are a widely accepted, efficacious surgical option to treat patients who have failed conservative management for overactive bladder, nonobstructive urinary retention, fecal incontinence, or pelvic pain. As with all implanted devices, there are associated risks for surgical site and implant infections. There are currently no clear published data or guidelines regarding
-
Radiation exposure during sacral neuromodulation lead placement: Multi-institutional descriptive study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-06 Ramzy T. Burns, Joanna Orzel, Paul Wadensweiler, Kimberly Kenne, Hannah Nakastuka, Natalija Kovacevic, Yashant Aswani, E. Ann Gormley, Priya Padamanabhan, Charles R. Powell, Annah Vollstedt, Elizabeth Takacs
Fluoroscopy has significantly improved lead placement and decreased surgical time for implantable sacral neuromodulation (SNM). There is a paucity of data regarding radiation and safety of fluoroscopy during SNM procedures. Our study aims to characterize fluoroscopy time and dose used during SNM surgery across multiple institutions and assess for predictors of increased fluoroscopy time and radiation
-
Therapeutic efficacy of 180-W GreenLight laser photoselective vaporization of the prostate for storage symptoms concomitant with benign prostatic obstruction and a search for outcome predictors Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-05 Yi-Chia Hsieh, Chang-Te Wang, Yao-Lin Kao, Yu-Sheng Cheng, Kuan-Yu Wu, Yi-Hui Ho, Ming-Syun Chuang, Yuan-Chi Huang, Yin-Chien Ou
Benign prostatic obstruction (BPO) is the most common cause of lower urinary tract symptoms among men. GreenLight photoselective vaporization of the prostate (GL-PVP) using a 180-W Xcelerated performance system (XPS) laser is a well-established method for treating BPO-induced voiding symptoms. However, its therapeutic effects on storage symptoms remain unclear. This study aimed to analyze the storage
-
Novel clinical diagnostic criteria based on noninvasive examination findings to predict the presence of urodynamic detrusor underactivity in men Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-02-01 Yoshihisa Matsukawa, Tsuyoshi Majima, Aya Mori, Shunsuke Kamizyo, Yushi Naito, Kazuna Matsuo, Shohei Ishida, Momokazu Gotoh, Shusuke Akamatsu
To investigate the usefulness of novel clinical diagnostic criteria based on noninvasive examination findings to diagnose urodynamic detrusor underactivity (DU) in men.
-
Should hormone replacement therapy (any route of administration) be considered in all postmenopausal women with lower urinary tract symptoms? Report from the ICI-RS 2023 Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Annika Taithongchai, Rayan Mohamed-Ahmed, Sanjay Sinha, William Gibson, Ilias Giarenis, Dudley Robinson, Paul Abrams
This International Consultation on Incontinence-Research Society report aims to summarize the evidence and uncertainties regarding the use of hormone replacement therapy by any route in the management of lower urinary tract symptoms (LUTS) including recurrent urinary tract infections (rUTI), with a review of special considerations for the elderly. Research question proposals to further this field have
-
Can apparently transient life events trigger long-term lower urinary tract symptoms? Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Sanjay Sinha, Pawan Vasudeva
One-time life events such as neurological injury can result in lifelong lower urinary tract symptoms (LUTS). However, it is unclear whether an apparently transient life event can also trigger long-term LUTS. This review examines the possibility of an association and hypothesizes the pathogenesis.
-
Is the insomnia phenotype the common denominator in LUTS during transition periods? An expert NOPIA research group review Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Irina Verbakel, George Boukheir, Mathijs de Rijk, Karlien Dhondt, Don Bliwise, Kim Pauwaert, Thomas Monaghan, Francois Hervé, Dirk Vogelaers, An Mariman, Karel Everaert
As people age, sleep stages and characteristics transition over time, but sleep deficits can profoundly impact health and cognitive functioning. Chronic sleep deprivation is linked to impaired attention and productivity, weakened immunity, increased risk of cardiovascular disease, obesity, and mental health disorders. Insomnia, obstructive sleep apnea syndrome, hormonal changes, nocturia, neurological
-
“What should be next in lifelong posterior hypospadias: Conclusions from the 2023 ERN eUROGEN and EJP-RD networking meeting” Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Rianne J. M. Lammers, George Tsachouridis, Marie K. Andersson, Sarah Dormeus, Teresa O. Ekerhult, Mikołaj Frankiewicz, Callum J. Gunn, Marcin Matuszewski, Keetje L. de Mooij, Rogier P. J. Schroeder, Michel I. A. Wyndaele, Zhentao Xing, Laetitia M. O. De Kort, Petra de Graaf
A congenital disease is for life. Posterior hypospadias, the severe form of hypospadias with a penoscrotal, scrotal, or perineal meatus, is a challenging condition with a major impact on lifelong quality of life.
-
Urethrolysis Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Lauren D. Gleich, Howard B. Goldman
1 INTRODUCTION Urethral obstruction is a potential risk following surgery for stress urinary incontinence (SUI). The diagnosis can be difficult due to wide variations in patient presentation, timing, and severity. The true incidence is likely underreported due to this variance. Current literature reports 2.5% to 24% of patients experience obstruction following anti-incontinence procedures, with 50%
-
Bladder outlet obstruction in women: Advanced evaluation Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Patrick M. Lec, Victor W. Nitti
Herein, we provide a review of the indications, practical considerations, and interpretation of urodynamics (UDS) with or without fluoroscopy, as well as cystourethroscopy, for women with suspected bladder outlet obstruction (BOO).
-
Exploring lifelong overactive bladder: Transitions, evidence, and clinical implications; A modified Delphi process Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 George Bou Kheir, Irina Verbakel, Johan Vande Walle, Michel Wyndaele, Sanjay Sinha, Salvador Arlandis, Ann Raes, Paul Abrams, Alan Wein, François Hervé, Karel Everaert
Overactive bladder (OAB) is a prevalent urological condition characterized by urinary urgency, with or without urgency urinary incontinence, accompanied by increased daytime frequency and nocturia. However, the current definition of OAB lacks a specified time frame, hindering our understanding of the temporal aspects and transitions that occur within the OAB spectrum.
-
Lifelong LUTS: Understanding the bladder's role and implications across transition phases, a comprehensive review Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 George Bou Kheir, Irina Verbakel, Michel Wyndaele, Thomas F. Monaghan, Sanjay Sinha, Tove Holm Larsen, Erik Van Laecke, Lori Birder, François Hervé, Karel Everaert
Lower urinary tract symptoms (LUTSs) are a diverse array of urinary and pelvic dysfunctions that can emerge from childhood, extend through adulthood, and persist into older age. This narrative review aims to provide a comprehensive perspective on the continuum of LUTS and shed light on the underlying mechanisms and clinical implications that span across the lower urinary tract.
-
Introductory editorial: Lifelong LUTS, a matter of transition? Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Karel Everaert, George Bou Kheir, Johan Vande Walle, Irina Verbakel, François Hervé
The EPIC study has highlighted the prominence of nocturia as a crucial symptom of overactive bladder (OAB), intertwining OAB and nocturia with bladder, kidney, and brain functions.
-
Concluding editorial: Lifelong LUTS, a matter of transition? Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Karel Everaert, George Bou Kheir, Johan Vande Walle, Irina Verbakel, Salvador Arlandis, François Hervé
CONFLICTS OF INTEREST STATEMENT Karel Everaert has received grants from Ferring, Astellas, and Medtronic and support for travel to ICS2023 from Astellas to his institution. Johan Vande Walle has participated in advisory boards, safety boards and received speaker fees to his institution from Ferring and Astellas. Irina Verbakel has received support for participation in a conference abroad from the FWO—Belgium
-
Surgical management of bladder outlet obstruction due to functional and anatomical etiologies in women Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Pierre-Luc Dequirez, Meredith C. Wasserman, Benjamin M. Brucker
Bladder outlet obstruction (BOO) in women includes functional and anatomic etiologies. Primary bladder neck obstruction (PBNO), Fowler's syndrome (FS), and dysfunctional voiding (DV) are some examples of functional obstructions, whereas pelvic organ prolapse (POP), periurethral masses, and intragenic causes are some of the anatomic causes.
-
Is there evidence for pelvic floor muscle relaxation training in nonneurogenic female bladder outlet obstruction?—A narrative review Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Kari Bø
Functional bladder outlet obstruction (BOO) in women is postulated to be caused by pelvic floor muscle (PFM) dyssynergia or increased tone. The aim of the present review was to investigate the effect of PFM relaxation training on PFM tone and female BOO symptoms.
-
Safety and efficacy of an α1-blocker plus mirabegron compared with an α1-blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: a systematic review and network meta-analysis Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-30 Sender Herschorn, Tufan Tarcan, Yuan-Hong Jiang, Eric Chung, Farid Abdul Hadi, Achim Steup, Budiwan Sumarsono
Antimuscarinics and the β3-adrenoreceptor agonist, mirabegron, are commonly used for treating patients with overactive bladder (OAB) and α1-adrenoreceptor antagonists (α1-blockers) are the main pharmacological agents used for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). As these conditions commonly occur together, the aim of this systematic review was
-
The cost of lifelong LUTS—A systematic literature review Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-25 Tove Holm-Larsen, Mauro Van den Ende, Helena Goldstein Wendelboe, Irina Verbakel, George Bou Kheir, François Hervé, Karel Everaert
Lower urinary tract symptoms (LUTS) are highly prevalent and very bothersome. To support the best possible allocation of health care resources and to avoid unnecessary expenditures, it is important to understand and quantify the wide-ranging health care costs affecting people suffering from LUTS. We aimed at creating a foundation for exploring the cost of LUTS.
-
Detrusor underactivity after radical prostatectomy: A prospective observational study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-26 Maciej Oszczudlowski, Grzegorz Cymbalista, Konrad Bilski, Jakub Dobruch
To evaluate the impact of radical prostatectomy (RP) on bladder function with special interest in detrusor underactivity (DU) and to appraise clinical significance of DU in postprostatectomy patients.
-
What is the best first choice oral drug therapy for OAB? Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-25 Arun Sahai, Dudley Robinson, Paul Abrams, Alan Wein, Sachin Malde
The management of overactive bladder (OAB) involves lifestyle changes and conservative measures in the first instance with the use of liquid/dietary advice, weight loss, and bladder training. Thereafter oral pharmacotherapy is instigated in symptomatic patients. Antimuscarinics and beta 3 agonists form the main classes of drug therapy in this field. Views on what is the best first line OAB treatment
-
Validation of a simple body map to measure widespread pain in urologic chronic pelvic pain syndrome: A MAPP research network study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-25 J. Quentin Clemens, Kenneth Locke, J. Richard Landis, Karl Kreder, Larissa V. Rodriguez, Claire C. Yang, Frank F. Tu, Steven E. Harte, Andrew Schrepf, John T. Farrar, Siobhan Sutcliffe, Bruce D. Naliboff, David A. Williams, Niloofar Afari, Theresa Spitznagle, Bayley J. Taple, H. Henry Lai
In patients with urologic chronic pelvic pain syndrome (UCPPS), the presence of widespread pain appears to identify a distinct phenotype, with a different symptom trajectory and potentially different response to treatment than patients with pelvic pain only.
-
Urinary incontinence in middle-aged and older women with hip and knee osteoarthritis: An outpatient study of frequency and risk factors Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-22 Gisele A. S. C. de Melo, Vanessa de O. Fernandes, Henrique Silveira Costa, Ana Cristina Rodrigues Lacerda, Luciana N. Nobre, Débora F. de M. Vitorino, Alessandra de Carvalho Bastone
To investigate the frequency and the factors associated with urinary incontinence (UI) in a sample of middle-aged and older women with lower limb osteoarthritis (OA).
-
Urinary biomarkers in children with neurogenic and non-neurogenic lower urinary tract dysfunction: A systematic review and meta-analysis Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-18 Cagri Akin Sekerci, Selcuk Yucel, Tufan Tarcan
The aim of this systematic review is to assess urinary biomarkers studied in children with neurogenic and non-neurogenic lower urinary tract dysfunction (LUTD).
-
Does choice of anesthesia during stage 1 sacral neuromodulation testing influence outcomes? Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-18 Brendan T. Waldoch, Danyon J. Anderson, Sydney A. Narveson, R. Corey O'Connor, Michael L. Guralnick
Staged sacral neuromodulation (SNM) testing has been shown to have a high rate of progression to permanent implantation for the management of voiding dysfunction. Stage 1 lead placement (SNM-I) can be performed under monitored anesthesia care (MAC) or general anesthesia (GA). MAC allows for interpretation of sensory and motor responses to optimize lead placement while GA only permits for motor assessment
-
Investigation of anxiety levels in caregivers who perform clean intermittent catheterization on their children and affecting factors Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-18 Canan Sari, Birsel C. Demirbağ
The study aimed to determine the anxiety levels of caregivers who performed clean intermittent catheterization (CIC) on their children and the factors affecting them.
-
Patient reported outcomes of intermittent self-dilatation after direct vision internal urethrotomy Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-15 Lukas Scheipner, Doroteja Jankovic, Samra Jasarevic, Matthias Seidl, Julia V. Altziebler, Karl Pemberger, Klara C. Pohl, Günter Primus, Zhe Tian, Marianne Leitsmann, Sascha Ahyai
Long-term results on quality of life (QoL) as well as clinical outcomes of intermittent self-dilatation (ISD) of the urethra after direct visual internal urethrotomy (DVIU) are scarce. The aim of this study was to prospectively evaluate patient reported outcomes (PROs) on voiding symptoms and QoL in a large cohort of urethral stricture patients performing ISD.
-
Establishing initial resting abdominal pressure in children undergoing urodynamics Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-15 Sanjay Sinha, Pawan Vasudeva, Arabind Panda, Nikhil Khattar, Anita Patel, Mayank M. Agarwal
The International Continence Society recommends zeroing of transducers to the atmospheric pressure for invasive urodynamics. The range of abdominal pressure relative to atmospheric pressure is well-known in adults but has not been described in children. This prospective observational study was carried out to establish baseline abdominal in children.
-
Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-15 Ellen Kelsey, Jessica Wynn, Angela Holmes, Kathryn McLeod
The negative impact on quality of life and the economic-related burden to the patient and the health care system associated with idiopathic overactive bladder (iOAB) is well-documented. Intradetrusor OnabotulinumtoxinA (BTN/A) injections are a well-used treatment modality for the management of overactive detrusor refractory to medical management, with well-documented efficacy and safety profiles. There
-
Black box in overactive bladder: Central sensitization and its relationship with urinary symptom severity and quality of life Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-15 Seyda T. Celenay, Hafize Altay, Saliha B. Bulbul, Kemal Oskay
To examine central sensitization (CS), and to investigate the relationship between CS, and urinary symptom severity, and quality of life (QoL) in women with overactive bladder (OAB).
-
Open questions on lower urinary tract infections: Results of a Delphi consensus study Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-11 Valerio Iacovelli, Vincenzo Ficarra, Umberto Vittorio Maestroni, Manuela Tutolo, Enrico Finazzi Agrò
This is a Delphi study that aims to explore expert consensus regarding open questions in current literature evidence on lower urinary tract infections (UTIs). This manuscript deals with adults and analyzed the most recent guidelines and meta-analysis on the topic.
-
Bladder outflow obstruction in women: Clinical and basic evaluation Neurourol. Urodyn. (IF 2.0) Pub Date : 2024-01-10 Hossam S. El-Tholoth, Ali Alsulihem
Female bladder outflow obstruction is an underdiagnosed and undermanaged condition. This review article aims to illustrate the basic and clinical evaluation of patients who might have this condition.